ProfileGDS5678 / 1437421_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 52% 53% 53% 53% 53% 51% 58% 53% 51% 52% 52% 66% 52% 53% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3228552
GSM967853U87-EV human glioblastoma xenograft - Control 23.2962653
GSM967854U87-EV human glioblastoma xenograft - Control 33.29653
GSM967855U87-EV human glioblastoma xenograft - Control 43.2493653
GSM967856U87-EV human glioblastoma xenograft - Control 53.2430153
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.3346651
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.599658
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2912853
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2270651
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2503652
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2642952
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.9494566
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2775152
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2823853